Cost-effectiveness of a potential future helicobacter pylori vaccine in the Netherlands; the impact of varying the discount rate for health

被引：0
|
作者：
Klok, R. M.
de Vries, R.
van der Zeijst, B.
Postma, M. J.
机构：
[1] Vaccine Inst, NL-3720 AL Bilthoven, Netherlands
[2] Univ Groningen, GUIDE, Dept Social Pharm Pharmacoepidemiol & Pharmacothe, NL-9713 AV Groningen, Netherlands
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2006年 / 62卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：726 / 726
页数：1
相关论文
共 50 条
  • [31] Cost-Effectiveness Analysis of the Helicobacter Pylori Screening Programme in an Asymptomatic Population in China
    Feng, Tianyu
    Zheng, Zhou
    Xu, Jiaying
    Cao, Peng
    Gao, Shang
    Yu, Xihe
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (16)
  • [32] Cost-Effectiveness of Screening Helicobacter pylori for Gastric Cancer Prevention: a Systematic Review
    Maryam Sarmasti
    Manouchehr Khoshbaten
    Farhad Khalili
    Mahmood Yousefi
    Journal of Gastrointestinal Cancer, 2022, 53 : 1093 - 1103
  • [33] Cost-effectiveness of Helicobacter pylori screening and eradication to prevent stomach cancer in Spain
    Lopez-Saavedra, J.
    Martinez-Junquera, E.
    Fontan, L.
    Lopez-Torreblanca, M.
    Lorenzana-Sanchez, I.
    Alarcon, T.
    HELICOBACTER, 2020, 25 : 54 - 54
  • [34] Cost-Effectiveness Analysis of Helicobacter pylori Diagnostic Methods in Patients with Atrophic Gastritis
    Omata, Fumio
    Shimbo, Takuro
    Ohde, Sachiko
    Deshpande, Gautam A.
    Fukui, Tsuguya
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2017, 2017
  • [35] Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese
    Xie, Feng
    Luo, Nan
    Blackhouse, Gord
    Goeree, Ron
    Lee, Hin-Peng
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2008, 24 (01) : 87 - 95
  • [36] Cost-effectiveness and public health impact of typhoid conjugate vaccine introduction strategies in Bangladesh
    Weyant, Christopher
    Hooda, Yogesh
    Munira, Sira Jam
    Lo, Nathan C.
    Ryckman, Theresa
    Tanmoy, Arif M.
    Kanon, Naito
    Seidman, Jessica C.
    Garrett, Denise
    Saha, Samir K.
    Goldhaber-Fiebert, Jeremy D.
    Saha, Senjuti
    Andrews, Jason R.
    VACCINE, 2024, 42 (11) : 2867 - 2876
  • [37] Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness
    Burrows, Holly
    Antillon, Marina
    Gauld, Jillian S.
    Kim, Jong-Hoon
    Mogasale, Vittal
    Ryckman, Theresa
    Andrews, Jason R.
    Lo, Nathan C.
    Pitzer, Virginia E.
    VACCINE, 2023, 41 (04) : 965 - 975
  • [38] ESTIMATION OF THE HEALTH IMPACT AND COST-EFFECTIVENESS OF AN ADJUVANTED INFLUENZA VACCINE WITH ENHANCED EFFECTIVENESS AND DURABILITY OF EFFECT.
    Tuite, A.
    Fisman, D.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S179 - S179
  • [39] The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands
    Reckers-Droog, Vivian
    Enzing, Joost
    Brouwer, Werner
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2024, 25 (08): : 1449 - 1459
  • [40] Impact of patient adherence on the cost-effectiveness of noninvasive tests for the initial diagnosis of Helicobacter pylori infection in the United States
    Boklage, Susan H.
    Mangel, Allen W.
    Ramamohan, Varun
    Mladsi, Deirdre
    Wang, Tao
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 45 - 55
12345